BIOXINESS PHARMACEUTICALS, INC. — Form D
BIOXINESS PHARMACEUTICALS, INC. of HERCULES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-21. The offering totals $1.0M, of which $502K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-09-21
- Form: D
- Accession: 0001470930-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $502K
- Remaining: $498K
- Investors: 29
- Date of first sale: 2016-09-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-271024
Issuer
- Name: BIOXINESS PHARMACEUTICALS, INC.
- CIK: 0001470930
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2007
- Address: 750 ALFRED NOBEL DRIVE SUITE 106, HERCULES, CA, 94547
- Phone: 510 724 1548
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Mansour Bassiri | Director | Hercules, CA |
| Susan Froshauer | Director | Farmington, CT |
| Matthew Kerby | Director | Hercules, CA |
| Constance McKee | Director | Hercules, CA |
| Clinton Severson | Director | Hercules, CA |
| Mansour Bassiri | Executive Officer | Hercules, CA |
| Mansour Bassiri | Promoter | Hercules, CA |
| Reza Ilkhani | Director | Hercules, CA |
| Reza Ilkhani | Executive Officer | Hercules, CA |
| Clint H Severson | Director | Hercules, CA |
Other filings by this issuer (2)
More